KaydedilenlerDerginizi ekleyin

Dergiler / Business and Management Studies: An International Journal / 2018 / Cilt: 6 - Sayı: 3

EFFICIENCY OF PHARMACEUTICAL CONSUMPTION IN TURKEY: BENCHMARKING WITH OECD BY DEA

TÜRKİYE’DE İLAÇ TÜKETİMİNİN VERİMLİLİĞİ: VZA YÖNTEMİ İLE OECD ÜLKELERİ KARŞILAŞTIRMASI

ÇAĞLA PINAR BOZOKLU
Yasemin KESKİN BENLİ
Sayfa
253–262
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

However, total efficiency level of Turkey got damaged by reason of its administrative limitations.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:After 1980s, consumers begin to focus more health-conscious behaviours and attitudes including the concept of consuming pharmaceutical products.
📊
Temel Bulgular & Veri:In this research, it is aimed to analyze Turkey’s benchmarking position among OECD countries in terms of pharmaceutical consumption efficiency. 15 OECD countries’ 5 years (2008-2012) analyzed by DEA-Malmquist TFP with the output-oriented and variable returns to scale methods.
💡
Sonuç & Katkı:However, total efficiency level of Turkey got damaged by reason of its administrative limitations.
🔬Tür:Araştırma Makalesi
📍Kapsam:2008-2012 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

After 1980s, consumers begin to focus more health-conscious behaviours and attitudes including the concept of consuming pharmaceutical products. Pharmaceutical consumption attitude is a natural outcome of this trend. In this research, it is aimed to analyze Turkey’s benchmarking position among OECD countries in terms of pharmaceutical consumption efficiency. 15 OECD countries’ 5 years (2008-2012) analyzed by DEA-Malmquist TFP with the output-oriented and variable returns to scale methods. TC index shows that Turkey had created more pharmaceutical consumption and longer life expectancy by using same amount of number of physicians, number of pharmacists, total public and private health insurance expenditures and number of doctor consultations. By the way, Turkey had embraced efficiency growth with the rate of 0.4 percent. However, total efficiency level of Turkey got damaged by reason of its administrative limitations.

Abstract

1980’lerden sonra, tüketiciler ilaç tüketimi de dahil olmak üzere, daha bilinçli bir şekilde sağlık odaklı davranışlar ve tutumlar geliştirmeye başlamıştır. İlaç tüketimi tutumu bu eğilimin doğal bir sonucudur. Bu araştırmada Türkiye’nin OECD ülkelerine arasında ilaç tüketimi verimliliği açısından karşılaştırmalı konumunun analiz edilmesi amaçlanmaktadır. 15 OECD ülkesinin 5 yıllık (2008-2012) panel verisi çıktı odaklı ve ölçeğe göre değişken getiri yöntemleri ile uygulanmışVZA-Malmquist TFV ile ölçülmüştür. Teknolojik değişim indeksi, Türkiye’nin aynı miktarda hekim, eczacı, sağlık sigorta harcaması (devlet ve özel) ve doktor muayenesi ile hem daha fazla ilaç tüketimi hem de daha uzun bir yaşam süresi beklentisi ortaya koyduğunu göstermektedir. Bu yıllar arasında Türkiye %0.4 verimlilik artışı yaratmıştır. Ancak, Türkiye’nin toplam verimlilik seviyesi yönetsel sınırlılıklardan ötürü düşüktür.

🔖

Bu Makaleye Atıf Yap

BOZOKLU, Ç. P., BENLİ, Y. K. (2018). EFFICIENCY OF PHARMACEUTICAL CONSUMPTION IN TURKEY: BENCHMARKING WITH OECD BY DEA. Business and Management Studies: An International Journal, Cilt: 6 - Sayı: 3, 253–262. https://ajindex.com/articles/184751

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (5)

  1. Angelidis, D., and Lyroudi. K. (2005), “The magnitude of off balance sheet activities for the evaluation of banking productivity. In International Conference on Finance, Copenhagen, September. Boussofiane, A., R. G., Dyson, and Thanassoulis.E. (1991), “Applied data envelopment analysis.” European Journal of Operational Research, Vol. 52, No. 1, pp. 1-15.doi: 0377-2217(91)90331-O Benli, Y. K. and Bozoklu. Ç. P. (2016), “Complexity of Measuring Advertising Efficiency: An Application of DEA Method in Turkey.” In Şule Erçetin (Ed.), Chaos, Complexity and Leadership 2014 Springer: Cham., pp. 193-207.
  2. Charnes, A., Cooper, W. W., and Rhodes E. (1978), “Measuring the efficiency of decision making units.” European Journal of Operational Research Vol. 2, pp. 429–444.doi: 0377-2217(78)90138-8 Crémieux, P. Y., Meilleur, M. C., Ouellette, P., Petit, P., Zelder, M., and Potvin K. (2005), “Public and private pharmaceutical spending as determinants of health outcomes in Canada.” Health economics Vol. 14, No. 2, pp. 107-116.doi: 10.1002/hec.922 Coelli, T.J. (1996), A Guide to DEAP Version 2.1: A Data Envelopment Analysis (Computer)Program. CEPA Working Paper 96/8, Department of Econometrics, University of New England. Cooper, W. W., Seiford, L. M., and Tone, K. (2007), “The CCR Model and production correspondence. Data envelopment analysis: A comprehensive text with models, applications, references and DEA-Solver Software, pp. 41-85.
  3. Deliktaş, E. (2002), “Türkiye özel sektör imalât sanayiinde etkinlik ve toplam faktör verimliliği analizi.” ODTÜ Gelişme Dergisi Vol. 29, No. 3–4, pp. 247–284.
  4. Dormont, B., Grignon, M., and Huber. H. (2006), “Health expenditure growth: reassessing the threat of ageing.” Health economics Vol. 15, No. 9, pp. 947-963.doi: 10.1002/hec.1165 El-Shinnawy, A. (2010), “Trends of Total Factor Productivity in Egypt's Pharmaceutical Industry: Evidence from The Nonparametric Malmquist Index Approach. In ERF 16th Annual Conference, Economic Research Forum, Cairo, May. Ersoy, K., Kavuncubasi, S., Ozcan, Y. A., and Harris J. M. (1997), “Technical efficiencies of Turkish hospitals: DEA approach.” Journal of Medical Systems Vol. 21, No. 2, pp. 67–74.doi: A:1022801222540 Frech, H. E., and Miller, R. D. (2004) “The effects of pharmaceutical consumption and obesity on the quality of life in the Organization of Economic Cooperation and Development (OECD) countries.” Pharmacoeconomics Vol. 22, No. 2, pp. 25-36.doi: 00019053-200422002-00004
  5. Hollingsworth, B., and Par